Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Brigit Biofarmaka Teknologi Tbk. (OBAT) vs Kedoya Adyaraya Tbk. (RSGK) Price & Performance

Brigit Biofarmaka Teknologi Tbk.Trade
Kedoya Adyaraya Tbk.Trade

Price performance (Past 24H)

Key statistics

Brigit Biofarmaka Teknologi Tbk. vs Kedoya Adyaraya Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 166.01B, 324K 24h volume), while Kedoya Adyaraya Tbk. trades at Rp1,030 (market cap 948.27B, 34.1K 24h volume). The key difference: Kedoya Adyaraya Tbk. is far larger — about 5.7× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (324K versus 34.1K). Which is the better fit depends on your goals.

OBATRSGK
Market Cap
166.01B948.27B
Volume
324K34.1K
Lot
3.24K341
Turnover
77.68M34.02M
Average Price
239.75997.71
Value
77.68M34.02M
Indicative Equilibrium Price
2401,030
Indicative Equilibrium Volume
12

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

OBAT
View details
RSGK
View details

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT

About Kedoya Adyaraya Tbk.

PT Kedoya Adyaraya Tbk (the Company) was established on June 11, 1990 based on Notarial Deed No. 104 of Darsono Purnomosidi, S.H., Notary in Jakarta. The Company started its commercial operations in 2011. PT Medikatama Sejahtera is the ultimate parent Company of the Company and its Subsidiaries.

Read more on RSGK